MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-02-0003212
Puerto Life Sciences Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.22 Cr
▼ 10% YoY
Net loss · FY 2025
₹5.99 Cr
Net margin -20.5%
EBITDA · FY 2025
₹5.59 Cr
EBITDA margin 19.1%
Authorised capital
₹22 Cr
Registered with MCA
Paid-up capital
₹20.03 Cr
Issued & subscribed
Open charges
₹71.36 Cr
Satisfied ₹28.19 Cr
Company age
8 yrs
Est. 2018
Employees · EPFO
144
Provident fund records
About Puerto Life Sciences Private Limited
Data last updated:
Puerto Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36990DL2018PTC340100. Its GSTIN is 07AAKCP1211D1ZY (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹22 Cr and a paid-up capital of ₹20.03 Cr. It is led by directors including Vardaan Sharma (Managing Director) and Anju Jolly.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – 24 G/F C S C Saini Enclave, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.22 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net loss of ₹5.99 Cr (net margin -20.5%) and EBITDA of ₹5.59 Cr (EBITDA margin 19.1%). Revenue has grown at a compounded annual rate (CAGR) of 655% over three years.
The company has about 144 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹71.36 Cr and satisfied charges of ₹28.19 Cr on record. Court records list 18 cases involving the company, including 7 filed by the company and 11 filed against it; 7 cases are pending. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in November 2020. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Medion Biotech Private Limited with revenue of ₹29.5 Cr.
Puerto Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0003212). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website puertolifesciences.com.
Company details
CIN U36990DL2018PTC340100
Registration Number 340100
Incorporation Date 04 October 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-02-0003212
Recognitions & Rankings of Puerto Life Sciences
Contact details
Puerto Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is puertolifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No – 24 G/F C S C Saini Enclave, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Puerto Life Sciences Private Limited, buy the company report.
Comprehensive company report
Puerto Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Puerto Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Puerto Life Sciences Private Limited, buy the company report.
Financials of Puerto Life Sciences Private Limited
FY 2025 filings availablePuerto Life Sciences Private Limited reported revenue of ₹29.22 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹29.22 Cr ▼ 10%
Net loss · FY 2025
₹5.99 Cr margin -20.5%
EBITDA · FY 2025
₹5.59 Cr margin 19.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 655%
EBITDA CAGR growth
3 years · compounded
▲ 87%
Revenue fell 10% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 655%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.99 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.1% | ||||
| Net Profit Margin | -20.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Puerto Life Sciences Private Limited, buy the company report.
Board of directors of Puerto Life Sciences Private Limited
Puerto Life Sciences has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anju Jolly Also directs: Nitvik Estates and Spaces LLP | Director | 04 Oct 2018 | 8 Years 0 Months | Current |
| Vardaan Sharma Also directs: Arm Infraestate Private Limited, Ashajyoti Exports Private Limited, Neelkanth Pharma Logistics Private Limited and 3 more | Managing Director | 05 Dec 2024 | 1 Years 10 Months | Current |
| Veerinder Pal Singh Also directs: Neelkanth Pharma Logistics Private Limited, Saviour Wellness Private Limited, Levikas Enterprises Private Limited and 1 more | Director | 25 Oct 2018 | 7 Years 11 Months | Current |
| Pramod Kumar Sharma Also directs: Shree Shyam Speciality Chemicals Private Limited, KSJN Chemicals Private Limited, SSND Medimart Private Limited and 5 more | Director | 17 Jul 2019 | 7 Years 3 Months | Current |
Peer comparison
Puerto Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medion Biotech Private Limited | ₹29.5 Cr (FY 2025) | 1.0% | Delhi, India | |||
| Rapross Pharmaceuticals Private Limited | ₹29.39 Cr (FY 2023) | 3.0% | Delhi, India | |||
| Puerto Life Sciences Private Limitedthis company | ₹29.22 Cr (FY 2025) | -₹5.99 Cr | -20.5% | -10.0% | 144 | Delhi, India |
| Saf Fermion Ltd. | ₹29.2 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Universal Pharmaceuticals Private Limited | ₹29.2 Cr (FY 2025) | 189.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Puerto Life Sciences Private Limited, buy the company report.
Auditor
Puerto Life Sciences Private Limited is audited by P V A R & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P V A R & ASSOCIATES | FY 2023 | 005223C |
Shareholding
The shareholding of Puerto Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Puerto Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹71.36 Cr
Satisfied charges
₹28.19 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Nov 2021 | 100518737 | Hdfc Bank Limited | ₹71.36 Cr | Open | |
| 07 Dec 2021 | 100517160 | The South Indian Bank Limited | ₹2 Cr | Satisfied | |
| 24 Mar 2021 | 100438225 | The South Indian Bank Limited | ₹1.19 Cr | Satisfied | |
| 12 Feb 2020 | 100328084 | The South Indian Bank Limited | ₹25 Cr | Satisfied |
To see the full charge records of Puerto Life Sciences Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Puerto Life Sciences Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in November 2020.
Total deals
3
Rights issues
2
Secondary share transfer
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2020 | Rights issue | ₹8.4 Cr | Investors: 3 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2019 | Rights issue | ₹3.9 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Puerto Life Sciences Private Limited has 18 court cases on record: 7 filed by Puerto Life Sciences, 11 filed against it. 7 cases are pending and 11 are disposed.
Total cases
18
Filed by the company
7
Filed against the company
11
Pending
7
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 6 | 4 |
| District courts | 3 | 3 | 3 |
| NCLT | 1 | 1 | 0 |
| NCLAT | 1 | 1 | 0 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Writ petition | Filed by the company against Jaipur Vidyut Vitran Nigam Limited (Jvvnl) | Pending |
| High Court of Rajasthan | Interim or miscellaneous application | Filed by the company against Jaipur Vidyut Vitran Nigam Limited | Pending |
| High Court of Delhi | Court case (O.M.P. (T) (COMM.)) | Filed against the company by Sterimax India Pvt Ltd | Disposed |
| High Court of Delhi | Arbitration matter | Filed by the company against Sterimax India Pvt. Ltd. | Disposed |
| District court, Shahdara, Delhi | Commercial suit | Filed against the company | Pending |
To see the full case history of Puerto Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Puerto Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Puerto Life Sciences Private Limited has a workforce of 144 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
144
Active EPFO establishments
1
Employee growth
16.13%
GST
Puerto Life Sciences has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCP1211D1ZY | Delhi | Active | 26 Oct 2018 |
| 08AAKCP1211D1ZW | Rajasthan | Active | 21 Jan 2019 |
To see the full GST registrations and return filing status of Puerto Life Sciences Private Limited, buy the company report.
Recent activity
Puerto Life Sciences Private Limited has 12 board changes on record since 2018: 4 appointments and 8 cessations. The latest: Vardaan Sharma was appointed as Managing Director on 05 Dec 2024.
AGM
Puerto Life Sciences Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 71.36 Cr registered on 30 Nov 2021 with Charge ID 100518737 was modified on 16 Jun 2025.
Filing
Puerto Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 07 Dec 2021 via Charge ID 100517160 with The South Indian Bank Limited was fully satisfied on 28 Jan 2025.
Charges
A charge registered on 24 Mar 2021 via Charge ID 100438225 with The South Indian Bank Limited was fully satisfied on 28 Jan 2025.
Appointed
Vardaan Sharma was appointed as Managing Director.
Ceased
Nilanchal Pradhan ceased to be Company Secretary.
Ceased
Ayan Sharma ceased to be Additional Director.
Ceased
Nisha Walia ceased to be Director.
Ceased
Abhishek Jain ceased to be Director.
Charges
A charge registered on 12 Feb 2020 via Charge ID 100328084 with The South Indian Bank Limited was fully satisfied on 18 Dec 2021.
Charges
A charge with The South Indian Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100517160 was registered on 07 Dec 2021.
11 earlier events are in the company report.
Frequently asked questions
Puerto Life Sciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 October 2018 (8+ years old) and is registered under CIN U36990DL2018PTC340100.
Puerto Life Sciences has 4 current directors:
- Vardaan Sharma - Managing Director
- Anju Jolly - Director
- Veerinder Pal Singh - Director
- Pramod Kumar Sharma - Director
The latest financial statements of Puerto Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Puerto Life Sciences is 07AAKCP1211D1ZY, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAKCP1211D1ZW (Rajasthan).
The CIN (Corporate Identification Number) of Puerto Life Sciences is U36990DL2018PTC340100. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Puerto Life Sciences has 18 court cases on record: 7 filed by the company and 11 filed against it. 7 are pending. Most are in the high courts.
Puerto Life Sciences was incorporated on 04 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Puerto Life Sciences has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in November 2020.
The peers of Puerto Life Sciences by revenue are Medion Biotech Private Limited, Rapross Pharmaceuticals Private Limited, Saf Fermion Ltd, Universal Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vardaan Sharma was appointed as Managing Director on 05 Dec 2024. Nilanchal Pradhan ceased to be Company Secretary on 01 Oct 2023. Ayan Sharma ceased to be Additional Director on 20 Mar 2023. Puerto Life Sciences has 12 board changes on record in total.
Yes, Puerto Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-02-0003212).